Microgel-based carriers enhance skeletal stem cell reprogramming towards immunomodulatory phenotype in osteoarthritic therapy

Skeletal stem cells(SSC)have gained attentions as candidates for the treatment of osteoarthritis due to their osteochondrogenic capacity.However,the immunomodulatory properties of SSC,especially under delivery operations,have been largely ignored.In the study,we found that Pdpn+and Grem1+SSC subpopulations owned immunoregulatory potential,and the single-cell RNA sequencing(scRNA-seq)data suggested that the mechanical activation of microgel carriers on SSC induced the generation of Pdpn+Grem1+Ptgs2+SSC subpopulation,which was potent at suppressing macrophage inflammation.The microgel carriers promoted the YAP nuclear translocation,and the activated YAP protein was necessary for the increased expression of Ptgs2 and PGE2 in microgels-delivered SSC,which further suppressed the expression of TNF-ɑ,IL-1βand promoted the expression of IL-10 in macrophages.SSC delivered with microgels yielded better preventive effects on articular lesions and macrophage activation in osteoarthritic rats than SSC without microgels.Chemically blocking the YAP and Ptgs2 in microgels-delivered SSC partially abolished the enhanced protection on articular tissues and suppression on osteoarthritic macrophages.Moreover,microgel carriers significantly prolonged SSC retention time in vivo without increasing SSC implanting into osteoarthritic joints.Together,our study demonstrated that microgel carriers enhanced SSC reprogramming towards immunomodulatory phenotype to regulate macrophage phenotype transformation for effectively osteoarthritic therapy by promoting YAP protein translocation into nucleus.The study not only complement and perfect the immunological mechanisms of SSC-based therapy at the single-cell level,but also provide new insight for microgel carriers in stem cell-based therapy.